NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/04/2026 15:46
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8,396.55 mln
Float155 mln
Earnings Date10/28/2026
EPS
0.38
Overpriced
P / E
131
Highly speculative
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.43
Manipulation likely
1-Year Forecast
56.00
Modest upside
Relative Strength
15
/ 100
Significantly lagging
Business Description
Alkermes is an Irish biopharmaceutical company founded in 1987 that develops and sells medicines for serious mental health and neurological conditions, including schizophrenia, bipolar disorder, and opioid and alcohol dependence. Its approved treatments are sold primarily in the United States, with additional operations in Ireland and other markets. The company also licenses its drug delivery technology to other pharmaceutical firms, supporting their efforts to develop and manufacture their own products.
